357 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
VRTX Vertex Pharmaceuticals Incorporated $175.8 $44.93B Downtrend
Article Searches
Celldex (CLDX) Q3 Earnings Beat Estimates, Revenues Miss http://www.zacks.com/stock/news/336654/celldex-cldx-q3-earnings-beat-estimates-revenues-miss?cid=CS-ZC-FT-336654 Nov 09, 2018 - Celldex (CLDX) reports narrower-than-expected loss in Q3. Revenues fall on reduced contract revenues and also miss estimates.
Spectrum (SPPI) Earnings and Sales Beat Estimates in Q3 http://www.zacks.com/stock/news/336648/spectrum-sppi-earnings-and-sales-beat-estimates-in-q3?cid=CS-ZC-FT-336648 Nov 09, 2018 - Spectrum (SPPI) reports narrower-than-expected loss in the third quarter and also beats on revenues. The company is on track to file a BLA for Rolontis by year end.
Jazz Pharma (JAZZ) Beats on Q3 Earnings, Lowers Sales View http://www.zacks.com/stock/news/336354/jazz-pharma-jazz-beats-on-q3-earnings-lowers-sales-view?cid=CS-ZC-FT-336354 Nov 08, 2018 - Jazz Pharmaceuticals (JAZZ) lowers sales guidance for 2018. Stock declines 14% following the release of third-quarter earnings.
Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q3, DRNA Soars on LLY Deal http://www.zacks.com/stock/news/333667/biotech-stock-roundup-celgene-amgen-vertex-impress-in-q3-drna-soars-on-lly-deal?cid=CS-ZC-FT-333667 Oct 31, 2018 - Impressive third-quarter results by most biotech bigwigs were the key highlights of the week. Most companies upped their guidance.
Is a Beat in Store for CRISPR (CRSP) This Earnings Season? http://www.zacks.com/stock/news/332711/is-a-beat-in-store-for-crispr-crsp-this-earnings-season?cid=CS-ZC-FT-332711 Oct 30, 2018 - We expect CRISPR (CRSP) to provide updates on its pipeline candidates in the third quarter of 2018.
Vertex: Great Company But Too Pricey https://seekingalpha.com/article/4215409-vertex-great-company-pricey?source=feed_sector_healthcare Oct 29, 2018 - Vertex is a $42 bn market cap biotech company that showed unprecedented success over the last several years in the treatment of cystic fibrosis.We believe that Vertex will eventually be able to treat
VRTX: H.C. Wainwright ups to Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20181026072717 Oct 26, 2018 - H.C. Wainwright issues rating change for VRTX
Vertex Pharmaceuticals (VRTX) Q3 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4214104-vertex-pharmaceuticals-vrtx-q3-2018-results-earnings-call-transcript?source=feed_sector_healthcare Oct 24, 2018 - Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)Q3 2018 Earnings CallOctober 24, 2018 4:30 pm ETExecutivesMichael Partridge - Vertex Pharmaceuticals, Inc.Jeffrey M. Leiden - Vertex Pharmaceuticals, Inc.Ian
Vertex Pharmaceuticals Incorporated 2018 Q3 - Results - Earnings Call Slides https://seekingalpha.com/article/4214056-vertex-pharmaceuticals-incorporated-2018-q3-results-earnings-call-slides?source=feed_sector_healthcare Oct 24, 2018 - The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2018 Q3 earnings call.
Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT http://www.zacks.com/stock/news/330069/biotech-stocks-earnings-lineup-for-oct-24-vrtx-alxn-srpt?cid=CS-ZC-FT-330069 Oct 23, 2018 - Three biotech stocks are scheduled to release their third-quarter results on Oct 24. Let's take a look at how these companies are poised ahead of their earnings release.

Pages: 123456...36

Page 1>

Related Companies

Name Exchange Price Mkt Cap
SHPG Shire plc NASDAQ $176.25 $46.08B
ZTS Zoetis Inc. NYSE $88.3 $42.55B
REGN Regeneron Pharmaceuticals, Inc. NASDAQ $386.665 $41.78B
CELG Celgene Corporation NASDAQ $87.23 $61.35B
AGN Allergan plc. NYSE $184.29 $62.56B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Vertex Pharmaceuticals Incorporated